Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerlym S Porter

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
British Journal of Haematology|November 20, 2024
Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation ConsortiumJennifer N Longoria, Kristen E Howell, Jerlym S Porter, et al.
Journal of Sickle Cell Disease|June 17, 2025
Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of healthLori E Crosby, Desireé N Williford, Allison A King, et al.
British Journal of Haematology|February 11, 2021
Cognitive performance as a predictor of healthcare transition in sickle cell diseaseAnjelica C Saulsberry-Abate, Marita Partanen, Jerlym S Porter, et al.
British Journal of Haematology|October 20, 2022
Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controlsAndrew M Heitzer, Jane E Schreiber, Xiaomeng Yuan, et al.
Blood Advances|February 3, 2026
EFFECTIVENESS OF HEALTHCARE TRANSITION INTERVENTIONS FOR SICKLE CELL DISEASEMelissa Azul, Tarun Aurora, Jerlym S Porter, et al.
Cancer|July 11, 2019
Racial and ethnic disparities in neurocognitive, emotional, and quality-of-life outcomes in survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyStephanie B Dixon, Nan Li, Yutaka Yasui, et al.
Frontiers in Pharmacology|January 5, 2026
Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims dataAyesha Mukhopadhyay, Matthew P Smeltzer, Judy Dudley, et al.
Blood Advances|September 22, 2023
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell diseaseJane S Hankins, Donald Brambilla, Michael B Potter, et al.
Pediatric Blood & Cancer|May 26, 2018
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthoodJane S Hankins, Jeremie H Estepp, Jason R Hodges, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
British Journal of Haematology|November 20, 2024
Depression, sleep and pain affect instrumental activities of daily living through cognitive functioning in adults with sickle cell disease: A report from the Sickle Cell Disease Implementation ConsortiumJennifer N Longoria, Kristen E Howell, Jerlym S Porter, et al.
Journal of Sickle Cell Disease|June 17, 2025
Recommended measurement protocols for sickle cell disease in the PhenX toolkit: psychosocial factors and social determinants of healthLori E Crosby, Desireé N Williford, Allison A King, et al.
British Journal of Haematology|February 11, 2021
Cognitive performance as a predictor of healthcare transition in sickle cell diseaseAnjelica C Saulsberry-Abate, Marita Partanen, Jerlym S Porter, et al.
British Journal of Haematology|October 20, 2022
Working memory and school readiness in preschool children with sickle cell disease compared to demographically matched controlsAndrew M Heitzer, Jane E Schreiber, Xiaomeng Yuan, et al.
Blood Advances|February 3, 2026
EFFECTIVENESS OF HEALTHCARE TRANSITION INTERVENTIONS FOR SICKLE CELL DISEASEMelissa Azul, Tarun Aurora, Jerlym S Porter, et al.
Cancer|July 11, 2019
Racial and ethnic disparities in neurocognitive, emotional, and quality-of-life outcomes in survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyStephanie B Dixon, Nan Li, Yutaka Yasui, et al.
Frontiers in Pharmacology|January 5, 2026
Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims dataAyesha Mukhopadhyay, Matthew P Smeltzer, Judy Dudley, et al.
Blood Advances|September 22, 2023
A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell diseaseJane S Hankins, Donald Brambilla, Michael B Potter, et al.
Pediatric Blood & Cancer|May 26, 2018
Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthoodJane S Hankins, Jeremie H Estepp, Jason R Hodges, et al.
Pageof 5